Ottawa Hospital Research Institute

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 2001-01-01

Employees: 5K

Market Cap: -

Website: http://www.ohri.ca

Clinical Trials

Feasibility Study of Presurgical Hormone Therapy (Anastrozole) in Breast Cancer Patients

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Drug: Anastrozole

First Posted Date: 2013-10-31

Last Posted Date: 2016-02-04

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 20

Registration Number: NCT01972984

Locations: 🇨🇦
The Ottawa Hospital, Ottawa, Ontario, Canada

Evaluation of Safety Mechanisms of Renal Radioablation(RSRA)for Uncontrolled Hypertension

Terminated

Conditions: Uncontrolled Hypertension

First Posted Date: 2013-10-22

Last Posted Date: 2015-02-10

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 4

Registration Number: NCT01966952

Locations: 🇨🇦
The Hypetension Unit of The Ottawa Hospital, Ottawa, Ontario, Canada

Buttonhole Versus Step Ladder Cannulation in High Dose Hemodialysis

Not Applicable

Completed

Conditions: Renal Failure

Interventions: Procedure: Buttonhole needling technique

First Posted Date: 2013-10-14

Last Posted Date: 2020-09-29

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 14

Registration Number: NCT01962025

Locations: 🇨🇦
Ottawa Hospital, Ottawa, Ontario, Canada
🇨🇦
Foothills Hospital, Calgary, Alberta, Canada
🇨🇦
London Health Sciences Centre, London, Ontario, Canada

Effects of Vitamin D in Patients With Breast Cancer

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Other: Placebo
Drug: Vitamin D3

First Posted Date: 2013-09-23

Last Posted Date: 2016-02-03

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 83

Registration Number: NCT01948128

Locations: 🇨🇦
The Ottawa Hospital Woman's Breast Health Centre, Ottawa, Ontario, Canada

Observational Study of Safety and Outcomes After Minimally Invasive Surgery for Intracerebral Hemorrhage

Withdrawn

Conditions: Intracerebral Hemorrhage

Interventions: Other: Clinical Measurement

First Posted Date: 2013-08-12

Last Posted Date: 2014-04-04

Lead Sponsor: Ottawa Hospital Research Institute

Registration Number: NCT01920763

Locations: 🇨🇦
The Ottawa Hospital, Ottawa, Ontario, Canada

Prevention of Chemotherapy Induced Nausea and Vomiting in Breast Cancer Patients.

Phase 4

Conditions: Emesis

Interventions: Drug: Dexamethasone, Ondansetron, Aprepitant

First Posted Date: 2013-08-01

Last Posted Date: 2017-01-30

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 323

Registration Number: NCT01913990

Locations: 🇨🇦
The Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada

The ODYSSEY TRIAL Phase IV Trial Evaluating the Palliative Benefit of Pamidronate or Zoledronic Acid in Breast Cancer

Phase 4

Completed

Conditions: Breast Cancer

Interventions: Drug: Pamidronate
Drug: Zoledronic acid
Drug: placebo

First Posted Date: 2013-07-25

Last Posted Date: 2017-07-07

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 74

Registration Number: NCT01907880

Locations: 🇨🇦
The Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada

A Drug Interaction Study Investigating the Effect of Rifabutin on the Pharmacokinetics of Maraviroc

Phase 1

Completed

Conditions: HIV Infection
HIV-1 Infection
Mycobacterium Avium Complex (MAC)

Interventions: Drug: Rifabutin
Drug: Maraviroc

First Posted Date: 2013-07-10

Last Posted Date: 2020-03-10

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 15

Registration Number: NCT01894776

Locations: 🇨🇦
The Ottawa Hospital -General Campus, Ottawa, Ontario, Canada

Trial of Electrical Versus Pharmacological Cardioversion for RAFF in the ED

Not Applicable

Completed

Conditions: Atrial Fibrillation
Atrial Flutter

Interventions: Device: drug-shock vs shock only

First Posted Date: 2013-07-02

Last Posted Date: 2019-07-22

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 396

Registration Number: NCT01891058

Locations: 🇨🇦
Vancouver General Hospital, Vancouver, British Columbia, Canada
🇨🇦
Rockyview General Hospital, Calgary, Alberta, Canada
🇨🇦
Foothills Medical Centre, Calgary, Alberta, Canada

and more 7 locations

Lung Volume Recruitment for Lung Function and Cough Impairment in Multiple Sclerosis

Not Applicable

Conditions: Multiple Sclerosis

Interventions: Procedure: Lung volume recruitment

First Posted Date: 2013-07-02

Last Posted Date: 2016-03-31

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 35

Registration Number: NCT01891071

Locations: 🇨🇦
The Ottawa Hospital, Ottawa, Ontario, Canada
🇨🇦
Hôpital Charles-LeMoyne, Greenfield Park, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy